Home › Gastro-enteropancreatic neuroendocrine tumor › Tennessee
Gastro-enteropancreatic neuroendocrine tumor clinical trials in Tennessee
3 studies for Gastro-enteropancreatic neuroendocrine tumor are looking for participants at sites in Tennessee.
Cities in Tennessee
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Research Facility, Nashville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07165132Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Tennessee Oncology, Nashville
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Sep 11, 2026 · NCT06784752Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Vanderbilt-Ingram Cancer Center, Nashville
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.